Bevacizumab and beyond: investigating the role of combination therapies in the management of retinal diseases
Crossref DOI link: https://doi.org/10.1007/s10792-025-03807-9
Published Online: 2025-10-23
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hor, Masoumeh Sadat
Rahgozar, Soheila
Souri, Zahra
Malekahmadi, Mohammad
Text and Data Mining valid from 2025-10-23
Version of Record valid from 2025-10-23
Article History
Received: 3 July 2025
Accepted: 12 October 2025
First Online: 23 October 2025
Declarations
:
: The authors declare no conflict of interest.
: Not applicable.